Related Experiment Video
Updated: Jul 10, 2025

06:17
Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
Published on: February 28, 2025
537
Covalent fragment libraries in drug discovery-Design, synthesis, and screening methods
Brad Hocking1, Alan Armstrong2, David J Mann1
1Department of Life Sciences, Imperial College London, London, United Kingdom.
Progress in Medicinal Chemistry
|November 19, 2023
Summary
Covalent fragment-based drug discovery (FBDD) methods are crucial for developing new drugs. This chapter details covalent FBDD principles, library design, synthesis, and screening, offering practical insights and future directions.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Chemical Biology
Background:
- The increasing popularity of drugs with a covalent mode of action necessitates advanced drug discovery techniques.
- Traditional fragment-based drug discovery (FBDD) methods require adaptation for covalent applications.
- There is a growing demand for well-validated covalent FBDD approaches.
Purpose of the Study:
- To provide an in-depth exploration of covalent fragment reactivity.
- To detail principles and practical applications of covalent library design, synthesis, and screening.
- To discuss the future of covalent FBDD and propose potential advancements.
Main Methods:
- Exploration of covalent fragment reactivity principles.
- In-depth review of covalent library design strategies.
- Analysis of synthesis and screening methods for covalent fragments.
- Focus on literature examples for practical application.
Main Results:
- Comprehensive overview of covalent FBDD principles and methodologies.
- Practical guidance on designing and screening covalent fragment libraries.
- Identification of key challenges and opportunities in the field.
Conclusions:
- Covalent FBDD is a rapidly evolving field with significant therapeutic potential.
- Standardized and validated methods are crucial for advancing covalent FBDD.
- Future research should focus on innovative library design and screening technologies.
Related Concept Videos
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Drug-Receptor Bonds
2.9K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.9K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Structure-Activity Relationships and Drug Design
733
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
733

